Oscar Groet
Director Ejecutivo en K.D. Pharma Bexbach GmbH .
Perfil
Oscar Groet is currently the Chief Executive Officer at K.D.
Pharma Bexbach GmbH since 2013.
He is also the Chief Executive Officer at KD Pharma Group SA, Director at Sancilio & Co., Inc., and Managing Director at O³ Holding GmbH.
In the past, he worked as a Director at SAIC Iveco Commercial Vehicle Investment Co., Ltd.
and Sancilio Pharmaceuticals Co., Inc.
Cargos activos de Oscar Groet
Empresas | Cargo | Inicio |
---|---|---|
K.D. Pharma Bexbach GmbH
K.D. Pharma Bexbach GmbH Pharmaceuticals: MajorHealth Technology K.D. Pharma Bexbach GmbH designs and develops technologies for the extraction and purification of fatty acids. It also supplies custom Omega-3 formulations to clients in the pharmaceutical industry. The firm's products are available as ethyl esters, free fatty acids, and triglycerides. The company was founded by Rudolf Krumbholz and Michael Dorscheid in 1988 and is headquartered in Bexbach, Germany. | Director Ejecutivo | 01/05/2013 |
Sancilio & Co., Inc.
Sancilio & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio & Co., Inc. operates as specialty pharmaceutical company. It develops and markets based products including those based on the proprietary Advanced Lipid Technologies platform. The company was founded by Frederick D. Sancilio in 2005 and is headquartered in Riviera Beach, FL. | Director/Miembro de la Junta | - |
O³ Holding GmbH
O³ Holding GmbH Financial ConglomeratesFinance O³ Holding GmbH is an investment holding private company based in Bexbach, Germany. The German company functions as an investment holding company. The CEO of the company is Oscar Groet. | Director Ejecutivo | - |
KD Pharma Group SA
KD Pharma Group SA Pharmaceuticals: MajorHealth Technology KD Pharma Group SA is a contract manufacturer specializing in the development of pharmaceutical and nutraceutical products. The private company is based in Bioggio, Switzerland, and has subsidiaries in Austria. The Swiss company is also one of the world's largest producers of omega-3 fatty acids, with a presence in several countries and employing over 500 people. KD Pharma Group uses state-of-the-art technology protected by numerous patents, and its quality assurance adheres to the pharmacopoeia, the European pharmacopoeia, or the group GMP purity parameters in its omega-3 fatty acids. The company was founded in 1981, and the CEO is Oscar Groet. | Director Ejecutivo | - |
Antiguos cargos conocidos de Oscar Groet.
Empresas | Cargo | Fin |
---|---|---|
SAIC Iveco Commercial Vehicle Investment Co., Ltd.
SAIC Iveco Commercial Vehicle Investment Co., Ltd. Financial ConglomeratesFinance SAIC Iveco Commercial Vehicle Investment Co., Ltd. functions as an investment holding Chinese company. The joint venture company is based in Shanghai, China. and has subsidiaries in China. | Director/Miembro de la Junta | - |
Sancilio Pharmaceuticals Co., Inc.
Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio Pharmaceuticals Co. engaged in the development and manufacture of pharmaceutical products. Its product platform, advanced lipid technologies, focuses on the treatment of diseases and disorders related to lipids such as sickle cell, short bowel, severe hypertriglyceridemia and non-alcoholic fatty liver. The company was founded by Frederick Sancilio in October 2004 and was headquartered in Riviera Beach, FL. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 6 |
---|---|
SAIC Iveco Commercial Vehicle Investment Co., Ltd.
SAIC Iveco Commercial Vehicle Investment Co., Ltd. Financial ConglomeratesFinance SAIC Iveco Commercial Vehicle Investment Co., Ltd. functions as an investment holding Chinese company. The joint venture company is based in Shanghai, China. and has subsidiaries in China. | Finance |
Sancilio & Co., Inc.
Sancilio & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio & Co., Inc. operates as specialty pharmaceutical company. It develops and markets based products including those based on the proprietary Advanced Lipid Technologies platform. The company was founded by Frederick D. Sancilio in 2005 and is headquartered in Riviera Beach, FL. | Commercial Services |
K.D. Pharma Bexbach GmbH
K.D. Pharma Bexbach GmbH Pharmaceuticals: MajorHealth Technology K.D. Pharma Bexbach GmbH designs and develops technologies for the extraction and purification of fatty acids. It also supplies custom Omega-3 formulations to clients in the pharmaceutical industry. The firm's products are available as ethyl esters, free fatty acids, and triglycerides. The company was founded by Rudolf Krumbholz and Michael Dorscheid in 1988 and is headquartered in Bexbach, Germany. | Health Technology |
Sancilio Pharmaceuticals Co., Inc.
Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio Pharmaceuticals Co. engaged in the development and manufacture of pharmaceutical products. Its product platform, advanced lipid technologies, focuses on the treatment of diseases and disorders related to lipids such as sickle cell, short bowel, severe hypertriglyceridemia and non-alcoholic fatty liver. The company was founded by Frederick Sancilio in October 2004 and was headquartered in Riviera Beach, FL. | Commercial Services |
O³ Holding GmbH
O³ Holding GmbH Financial ConglomeratesFinance O³ Holding GmbH is an investment holding private company based in Bexbach, Germany. The German company functions as an investment holding company. The CEO of the company is Oscar Groet. | Finance |
KD Pharma Group SA
KD Pharma Group SA Pharmaceuticals: MajorHealth Technology KD Pharma Group SA is a contract manufacturer specializing in the development of pharmaceutical and nutraceutical products. The private company is based in Bioggio, Switzerland, and has subsidiaries in Austria. The Swiss company is also one of the world's largest producers of omega-3 fatty acids, with a presence in several countries and employing over 500 people. KD Pharma Group uses state-of-the-art technology protected by numerous patents, and its quality assurance adheres to the pharmacopoeia, the European pharmacopoeia, or the group GMP purity parameters in its omega-3 fatty acids. The company was founded in 1981, and the CEO is Oscar Groet. | Health Technology |
- Bolsa de valores
- Insiders
- Oscar Groet